Pub Date : 2024-08-01DOI: 10.1007/s12088-024-01350-2
Nikita Bahuguna, Divya Venugopal, Nishant Rai
The potential of innovative and alternative probiotic-based antifungal drugs to treat severe biofilm-associated infections has increased demand in recent years. A potentially fatal systemic fungal disease, candidiasis mostly affects the skin and mucous membranes lining inside body cavities such as the nose, mouth, lips, eyes, ears, and genital area. Candida-induced biofilms are densely arranged communities with specific structures that adhere to the surfaces of embedded devices, are covered by an extracellular matrix, and act as an essential virulent factor. It is crucial to explore innovative approaches to aid in treating such fungal illnesses because conventional medications are no longer effective in treating candidiasis. Researchers have been driven to identify the triggers that cause biofilm to grow and mature due to the difficulties involved with biofilm-related disorders. There are still several challenges in Candidasis disease management in clinical settings. A potentially effective approach involves utilising probiotic microorganisms and/or their metabolites, including probiotic yeast Saccharomyces boulardii. It has a significant role in the prevention or treatment of intestinal disorders. The virulence factors, hyphae production, adhesion, and biofilm development of Candida albicans, a significant human fungal pathogen, are influenced by S. boulardii cells and their metabolite, including capric acid. This article is exploring the biotherapeutic potential of probiotic, particularly S. boulardii against Candidiasis and highlighting the health benefits of probiotics on human health.
{"title":"Biotherapeutic Potential of Probiotic Yeast Saccharomyces boulardii Against Candida albicans Biofilm","authors":"Nikita Bahuguna, Divya Venugopal, Nishant Rai","doi":"10.1007/s12088-024-01350-2","DOIUrl":"https://doi.org/10.1007/s12088-024-01350-2","url":null,"abstract":"<p>The potential of innovative and alternative probiotic-based antifungal drugs to treat severe biofilm-associated infections has increased demand in recent years. A potentially fatal systemic fungal disease, candidiasis mostly affects the skin and mucous membranes lining inside body cavities such as the nose, mouth, lips, eyes, ears, and genital area. Candida-induced biofilms are densely arranged communities with specific structures that adhere to the surfaces of embedded devices, are covered by an extracellular matrix, and act as an essential virulent factor. It is crucial to explore innovative approaches to aid in treating such fungal illnesses because conventional medications are no longer effective in treating candidiasis. Researchers have been driven to identify the triggers that cause biofilm to grow and mature due to the difficulties involved with biofilm-related disorders. There are still several challenges in Candidasis disease management in clinical settings. A potentially effective approach involves utilising probiotic microorganisms and/or their metabolites, including probiotic yeast <i>Saccharomyces boulardii</i>. It has a significant role in the prevention or treatment of intestinal disorders. The virulence factors, hyphae production, adhesion, and biofilm development of <i>Candida albicans</i>, a significant human fungal pathogen, are influenced by <i>S. boulardii</i> cells and their metabolite, including capric acid. This article is exploring the biotherapeutic potential of probiotic, particularly <i>S. boulardii </i>against Candidiasis and highlighting the health benefits of probiotics on human health.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"295 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141868673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The food and beverage industries often utilize synthetic colors to enhance aesthetics, despite concerns about their potential health impacts. Consequently, there is a demand for alternative colors; however, the cultivation of non-toxic natural colors proves to be expensive. This study aims to increase the production of prodigiosin, a promising food color, utilizing pigment-producing microorganisms and agro-industrial waste as a substrate through solid-state fermentation technology. The research begins with screening suitable substrates, including wheat bran powder and rice bran, and orange peel powder, along with strains such as Serratia marcescens bhu prodig and Serratia nematodiphilia (NCIM 5606). Subsequently, pigment production is optimized through amino acid supplementation, particularly focusing on sulfur-containing amino acids (methionine, cysteine, and cystine) and aromatic amino acids (tryptophan and tyrosine). Various analytical techniques, including UV-Visiblspectrophotometry, NMR, FTIR, HRMS, and ESI–MS, are employed to characterize the produced pigment. The findings underscore wheat bran powder as an excellent substrate for pigment production, especially with the strain Serratia nematodiphilia (NCIM 5606). Remarkably, tyrosine emerges as the most effective supplement for enhancing pigment yield, followed by cysteine, cystine, and methionine, with a concentration of 0.125 g/L. Additionally, the pigment obtained contains prodigiosin and its derivatives, with molecular weights of 323.19 Da, 309.18 Da, and 351.23 Da.
{"title":"Effect of Amino Acid Supplementation on Prodigiosin and its Derivatives Production Using Agro-Waste as Potential Substrate","authors":"Anisha Maurya, Kamlesh Kumar Maurya, Aparna Agarwal, Arunima Tripathi, Alisha Nandan, Parmjit S. Panesar, Ankita Hooda, Abhishek Dutt Tripathi","doi":"10.1007/s12088-024-01354-y","DOIUrl":"https://doi.org/10.1007/s12088-024-01354-y","url":null,"abstract":"<p>The food and beverage industries often utilize synthetic colors to enhance aesthetics, despite concerns about their potential health impacts. Consequently, there is a demand for alternative colors; however, the cultivation of non-toxic natural colors proves to be expensive. This study aims to increase the production of prodigiosin, a promising food color, utilizing pigment-producing microorganisms and agro-industrial waste as a substrate through solid-state fermentation technology. The research begins with screening suitable substrates, including wheat bran powder and rice bran, and orange peel powder, along with strains such as <i>Serratia marcescens bhu prodig</i> and <i>Serratia nematodiphilia</i> (NCIM 5606). Subsequently, pigment production is optimized through amino acid supplementation, particularly focusing on sulfur-containing amino acids (methionine, cysteine, and cystine) and aromatic amino acids (tryptophan and tyrosine). Various analytical techniques, including UV-Visiblspectrophotometry, NMR, FTIR, HRMS, and ESI–MS, are employed to characterize the produced pigment. The findings underscore wheat bran powder as an excellent substrate for pigment production, especially with the strain <i>Serratia nematodiphilia</i> (NCIM 5606). Remarkably, tyrosine emerges as the most effective supplement for enhancing pigment yield, followed by cysteine, cystine, and methionine, with a concentration of 0.125 g/L. Additionally, the pigment obtained contains prodigiosin and its derivatives, with molecular weights of 323.19 Da, 309.18 Da, and 351.23 Da.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"56 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141868844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Malaria is one of the most infectious disease that affects lives of million people throughout the world. Recently, there are several reports which indicate Plasmodium vivax (P. vivax) causing severe disease in infected patients from different parts of the world. For P. vivax disease severity, the data related to immunological and inflammatory status in human host is very limited. In the present study clinical parameters, cytokine profile and integrin gene were analyzed in P. vivax clinical patients. A total of 169 P. vivax samples were collected and categorized into severe vivax malaria (SVM; n = 106) and non-severe vivax malaria (NSVM; n = 63) according to WHO severity criteria. We measured host biomarker levels of interferon (IFN-γ), superoxide dismutase (SOD-1), interleukins viz. (IL-6, IL-10), and tumor necrosis factor (TNF-α) in patient plasma samples by ELISA for pro- and anti-inflammatory cytokines in severe malaria. Host integrin gene was genotyped using PCR assay. In our study, thrombocytopenia and anemia were major symptoms in severe P. vivax patients. In analyzed SVM and NSVM groups a significant increase in cytokine levels (IL-10, IL-6, and TNF-α) and anti-oxidant enzyme SOD-1 was found. Our study results also showed a higher pro-inflammatory (TNF-α, IL-6 and IFN-γ) to anti-inflammatory (IL-10) cytokine ratio in severe vivax patients. Integrin gene showed no mutation with respect to thrombocytopenic patients among clinically defined groups. It was observed that severe vivax cases had increased cytokine levels irrespective of age and sex of the patients along with thrombocytopenia and other clinical manifestations. The results of current findings could serve as baseline data for evaluating severe malaria parameters during P. vivax infections and will help in developing an effective biomarker for diagnosis.